You are here: vision-research.eu » People » Research Groups » United Kingdom » Coupland, Sarah

Liverpool Ocular Oncology Research Group (LOORG)

The Liverpool Ocular Oncology Research Group’s (LOORG’s) mission is to conduct high quality basic, translational and clinical research into the pathogenesis and treatment of adult ocular tumours that will improve patient care and survival. The Liverpool Ocular Oncology Research Group (LOORG) was established by Professor Sarah Coupland and Professor Bertil Damato in 2006. Prof. Coupland has since lead the basic science and translational research portfolio, in addition to being a Consultant Pathologist at the Royal Liverpool University Hospital.

A major strength of the LOORG is the close collaboration between ocular oncology clinicians (Lead, Professor Heimann), pathologists and basic scientists (Dr Sarah Lake and Dr Helen Kalirai) which ensures that the research we conduct addresses the key questions that will bring about improved survival and quality of life for ocular oncology patients.

Group Leader

Sarah E. Coupland
[more information]

Contact

University of Liverpool

Molecular and Clinical Cancer Medicine
Institute of Translational Medicine
6th Floor, Duncan Building
L69 3GA Liverpool
United Kingdom

Phone: +44(0)151 706 4494
Fax: +44(0)151 706 5826

E-mail:
s.e.coupland[at]liverpool.ac.uk

Website:
www.loorg.org

Current Research Projects

  • Project 1:
    Identification of regulators of metastasis in uveal melanoma
  • Project 2:
    Proteomic discovery of serum biomarkers in metastatic uveal melanoma
  • Project 3:
    Estimating survival prognosis after treatment of choroidal melanoma
  • Project 4:
    Gross chromosomal abnormalities in iris melanoma
  • Project 5:
    Molecular characteristics of metastatic liver lesions in uveal melanoma: the search for therapeutic targets

Research Groups

People

Related Research Groups

clinical laboratory testing
Oops, an error occurred! Code: 20191208071300d8ec53b7
conjunctiva
Oops, an error occurred! Code: 20191208071300e33ff989
disease gene mapping
Oops, an error occurred! Code: 20191208071300753636e4
gene/expression
Oops, an error occurred! Code: 2019120807130031ba941f
gene microarray
Oops, an error occurred! Code: 20191208071300a718d3c1
genetics
Oops, an error occurred! Code: 20191208071300b775f017
immunohistochemistry
Oops, an error occurred! Code: 20191208071300cf4eea13
iris
Oops, an error occurred! Code: 20191208071300af159bca
melanoma
Oops, an error occurred! Code: 20191208071300d1720cec
oncology
Oops, an error occurred! Code: 2019120807130079fb59e9
pathology: experimental
Oops, an error occurred! Code: 20191208071300b009cfbe
pathology: human
Oops, an error occurred! Code: 2019120807130049e5aaa4
pathology techniques
Oops, an error occurred! Code: 201912080713000c000a7a
tumors
Oops, an error occurred! Code: 2019120807130073e3c081
uvea
Oops, an error occurred! Code: 20191208071300e96a2ae7
vision and action
Oops, an error occurred! Code: 201912080713000d80b775
visual acuity
Oops, an error occurred! Code: 20191208071300393bfc79
uveal melanoma
Oops, an error occurred! Code: 20191208071300886ac187
conjunctival melanoma
Oops, an error occurred! Code: 201912080713006ce4d519
intraocular and ocular adnexal lymphomas
Oops, an error occurred! Code: 20191208071300cae5a714
pathology
Oops, an error occurred! Code: 20191208071300684aa6c2
translational studies
Oops, an error occurred! Code: 20191208071300bb2996c3